Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.
about
Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysisProliferative vitreoretinopathy: current and emerging treatmentsEfficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage.Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.Cataract surgery after intravitreal injection of triamcinolone acetonide.Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study.The effect of posterior subtenon methylprednisolone acetate in the refractory diabetic macular edema: a prospective nonrandomized interventional case series.Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis.Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitisIntraocular pressure after intravitreal injection of triamcinolone acetonide.Intravitreal triamcinolone acetonide for exudative age related macular degeneration.Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series studyExpression and functional roles of caspase-5 in inflammatory responses of human retinal pigment epithelial cellsFactors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eyeNational survey of the technique of intravitreal triamcinolone injection in the United Kingdom.Drug delivery from ocular implants.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.A case of radiation retinopathy of left eye after radiation therapy of right brain metastasis.Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidSterile endophthalmitis after intravitreal injections.A pilot study of intraocular use of intensive anti-inflammatory; triamcinolone acetonide to prevent proliferative vitreoretinopathy in eyes undergoing vitreoretinal surgery for open globe trauma; the Adjuncts in Ocular Trauma (AOT) Trial: study protUse of triamcinolone during vitrectomy surgery to visualize membranes and vitreous.Effects of triamcinolone acetonide injections with and without preservative.Pseudohypopyon after management of posterior capsule rupture using intracameral triamcinolone injection in cataract surgery.Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial.The cytotoxic and stress responses of human trabecular meshwork cells treated with triamcinolone acetonide.Intravitreal triamcinolone for intraocular inflammation and associated macular edema.Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony.Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide.Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema.Deposition of triamcinolone acetonide and its effect on soft tissue topography.Triamcinolone during pars plana vitrectomy for open globe trauma: a pilot randomised controlled clinical trial.
P2860
Q28086797-A822451B-25BC-4403-9783-EDED3B838573Q28274083-9B152946-FC35-4042-A13F-3F3B0D05C67AQ30491121-C8BC4C90-3721-4224-8CAB-C324B78A07B4Q30833907-D9B9C3BA-6CDD-43BE-B7C4-5A3B604E671BQ33201157-06D481F1-CAFF-4F83-BD8B-F450B87876FBQ33205922-5A18FE77-89C5-445E-BCF2-86D2B10AC124Q33206078-3900513B-217E-4DF9-BD79-A860EB0B66C4Q33238893-489EDFA8-FB61-4ADF-8D94-591263D6B609Q33282848-3EB2A38A-CF9D-4FFA-B6BB-D46C8215C6A4Q33817468-25CFE6C7-8BF7-4BE4-A6E9-1916239AEE0CQ34014954-6E372F21-4D95-44C6-A85D-A97BE3D291A4Q35590421-CEA842D8-0E00-435D-80AC-E1645EA12707Q35590749-A4C2A229-5F74-4297-ABAC-6CFD18A10B32Q35591314-5A14A66A-99BD-44C0-A5A1-DEE9721440CDQ35591490-267762AF-DFFF-4D51-B6A5-A633668DE9F9Q35592674-C9C19D09-7576-422B-AC13-9528EA393635Q35762992-3F70EF78-27D1-4625-829A-D6AF32AF8D48Q35769376-D70796D6-125F-4106-9137-4B2D073674F0Q36378901-30535FE1-E4F6-47F7-A5DE-B411D972DBDCQ36409058-79C8D00E-3161-4633-8E44-05DC381E6B03Q36441711-F5314548-1780-459B-81ED-45EF4852CCD3Q37222299-E7719379-D88F-477B-9341-0910693E0455Q37250122-C5587EB9-5CA1-43E6-BDA0-BF4BBE5DC68AQ38042910-6CAE7F7A-6DB4-486B-9E06-98FEE8424CB1Q41051623-16A62C42-A00B-429B-B6D2-F094290D23D3Q41280003-DF7A5B63-64C5-4EBB-973F-B3A50AF94EC8Q42410041-5BF17C64-0BD6-4F33-9815-89FD81774CB7Q42766286-09AD170F-6167-497D-B2F8-781652BF832FQ42772219-5EA1C116-141D-45F6-8B9D-7F2875E64C1FQ43059697-FD96F456-FDA9-43A8-BFA7-0C5D0A31916EQ43096392-88B3FD40-7A45-4C3A-9C23-51A1C1FD318CQ43740893-187A7F85-4579-4E60-8F31-83F96CAAE9D0Q44857263-2F96D6E5-7CB4-4D41-BBB4-1882BE04E134Q44952432-A4038895-D6E5-4079-A406-507EC99D0E1DQ46600808-0D79E0A3-212E-425B-8BE4-9754E18F6917Q46700893-A3C0EDCB-9827-4C07-96C4-33E51C2916A0Q46903674-11ABA41E-0DC2-4922-ADBE-5D388F42C914Q53131207-A109C9BB-E584-4BD5-BADC-587A85DA4BB6Q53291938-DAAA954C-538C-433A-8AC9-A1507460948C
P2860
Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@ast
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@en
type
label
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@ast
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@en
prefLabel
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@ast
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@en
P2093
P2860
P356
P1476
Intravitreal injection of crys ...... oliferative vitreoretinopathy.
@en
P2093
Panda-Jonas S
P2860
P304
P356
10.1136/BJO.84.9.1064
P407
P577
2000-09-01T00:00:00Z